Protective efficacy of selenium on N-nitrosodiethylamineinduced alterations in carbohydrate metabolism, studied in experimental hepatoma

Medical Science Research

Volumn 27, Issue 7, 1999, Pages 445-448

  Thirunavukkarasu, C ^a   Ebrahim, A S ^a   Babu, E ^a   Jagadeeswaran, R ^a   Sakthisekaran, D ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Carbohydrate metabolism; Hepatoma; N nitrosodiethylamine; Selenium

Indexed keywords

CARBOHYDRATE; DIETHYLNITROSAMINE; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCOLYTIC ENZYME; HEXOKINASE; LIVER ENZYME; SELENIUM; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCONEOGENESIS; GLYCOLYSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0032777910     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Carinci F, Felisatti P. Selenium and oral cancer. Minerva Stomalologica 1996:45:345-348.
2. Combs GF. Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998:79:179-192.
3. Combs GF Jr. Selenium and cancer. In: Biochemistry and Molecular Biohgv of Selenium, 2nd ed. Beijing: Chinese Academy of Science; 1995.
4. Mckenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunol Today 1998; 19:342-345.
5. Ringstad J, Jacobsen BK, Tretli S, Thomassen Y. Serum selenium concentration associated with risk of cancer. J Clin Pathol 1998; 41:454-457.
6. Buljevac M, Romic Z, Vucelic B, Banic M, Krznario Z, Plesko S. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma. Acta Med Croat 1996; 50(1):11-14.
7. Daoud AH, Griffin AC. Effect of retinoic acid butylated hydroxytoluene. propylgallate and selenium on 2-acetylaminofluorene induced hepatotoxicity. Cancer Lett 1985; 29:183-188.
8. Vega LA, Terradez P, Obrador E, Navarro J, Pellicer JA. Estrela JM. Inhibition of cancer growth and selective glutathione depletion in Elrhich tumour cells in vivo by extracellular ATP. Biochem J 1994; 298:99-105.
9. Eigenbordt E, Glossmann H. Glycolysis - one of the keys to cancer? Trends Pharmacol Sci 1980; 1:240-245.
10. Ruddon RW. Cancer Biology 2nd ed. New York: Oxford University Press; 1987.
11. Holroyde CP, Reichard GA. Carbohydrate metabolism in cancer cachexia. Cancer Treat Rep 1981 ; 65(5):55-60.
12. Lundholm K, Edstrom S, Karlberg I, Ekman L. Schersten T. Glucose turnover, gluconeogenesis from glycerol and estimation of net glucose cycling in cancer patients. Cancer 1982; 50:1142-1150.
13. Board M. Human S, Newsholme EA. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 1990; 265:503-509.
14. Newberne PM Bieri JG, Brigs GM, Nesheim MC. Control of diets in laboratory animal experimentation. Inst Lab Anim Resour News 1978; 21:A1-A12.
15. Yoshiji H, Nakae D, Kinugasa T, Matsuzaki M, Denda A, Tsuiki T, el al. Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver initiated with diethylnitrosamine and promoted by phénobarbital. Er J Cancer 1991; 64:839-842.
16. Branstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerentol 1957; 12:166-170.
17. Horrocks JE, Ward J, King J. A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Palhol 1963; 16:248-252.
18. King J. The transferases alanine and aspartate transaminases. In: King J (editor): Practical Clinical Enzymology. London: D. Van Nostrand Co. Ltd; 1965. pp. 121-138.
19. King J. The phosphohydrolases acid and alkaline phosphatases. In: King J (editor): Practical Clinical Enzymology. London: D. Van Nostrand Co. Ltd; 1965. pp.191-208.
20. Gansedo JM, Gancedo C. Fructose-1, 6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non-fermenting yeast. Arch Microbiol 1971; 76:132-138.
21. Fiske CH, Subbarow Y. The calorimetric determination of phosphorus. J Bio/ Chem 1925; 66:37500.
22. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951 ; 193:265-275.
23. Baggetto LG. Deviant energetic metabolism of glycolytic cancer cells. Biochemie 1992; 74:959-974.
24. Ebrahim AS. Babakrishnan K, Sakthisekaran D. Perchloroethyleneinduced alterations in glucose metabolism and their prevention by 2deoxy-D-glucose and vitamin E in mice. J Appl Toxicol 1996; 16(4):339-348.
25. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial. JAMA 1996; 276:1957-1963.
26. Gerbracht U, Eigenbrodt E, Simile MM, Pascale RM, Gaspa L, Damo L, et al. Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. AnticancRes 1993; 13(6A): 1765-1772.
27. Ahn YS, Zerban H, Grobholz R, Bannasch P. Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumours in rat kidney. Carcinogenesis 1992; 13:2329-2334.
28. Royds JA, Kennedy HJ, Little PV, Taylor CB, Triger DR. Serum aldolase isoenzymes in benign and malignant liver disease. Clin Chim Acta 1987; 167:237-246.
29. Schamhart DHJ, Poll VKW, Wijk RV. Comparative studies of glucose metabolism in HTC, RLC, MH,C, and Reuber H rat hepatoma cells. Cancer Res 1979:39:1051-1055.
30. IP C, Hayes C, Budnick RM, Ganther H. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res 1991; 51:595-600.
31. Ganther H. Selenium metabolism and function in man and animals. In: Brütter P, Schramel P (editors), Trace Elements - Analytical Chemistry in Medicine and Biology, Vol. 3. Berlin: Walter de Gruyter; 1984. pp. 3-24.
32. Lanfear J. Fleming J, Wu L, Webster G, Harrison PR. The selenium metabolite selenodiglutathione induces P5' and apoptosis: relevance to the chernopreventive effects of selenium? Carcinogenesis 1994; 15:1387-1392.
33. Yoshimura S, Watanabe K, Suemizu H, Onazawa T, Mizoguchi J, Tsuda K, et al. Tissue specific expression of the plasma glutathioneperoxidase gene in rat-kidney. J Biochem 1991: 109:918-923.
34. Berry MJ, Banu L, Larsen PR. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991 ; 349:438-440.
35. Hill KE, Lloyd RS, Yang JG, Read R, Burk RF. The cDNA for rat selenoprotein P contains 10 TGA codons in the open reading frame. J Biol Chem 1991; 266:10050-10053.
36. Jiang XR, Macey M, Lin HX, Newland AC. The anti-leukaemic effects and the mechanism of sodium selenite. Leukemia Res 1992: 16:347-352.
37. Yan L, Frenkel GD. Inhibition of cell attachment by selenite. Cancer Res 1992; 52:5803-5807.
38. Xia XM, Yu SY. Mechanism of the anticancer action of seleniuminfluence on glycolysis and its key enzyme. Chin J Oncol 1987; 9(4):255-257.